Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


New Jersey Physiomesh Litigation to Conduct Initial Case Management Conference in October

The multicounty litigation established in New Jersey’s Atlantic County Superior Court for all hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Flexible Composite Mesh will soon get underway. According to an Order dated August 20th, the Court will conduct its first … Continue reading

Johnson & Johnson Faces Another Talcum Powder Mesothelioma Trial, This Time in California

A jury in California has been convened to hear evidence in yet another trial involving the alleged link between Johnson & Johnson’s talcum powder and mesothelioma, a deadly form of cancer caused by asbestos exposure. According to a talcum powder … Continue reading

Vaginal Rejuvenation Lawsuit Filed Over MonaLisa Touch Marketing

A new class action lawsuit accuses Cynosure of deceptively marketing its MonaLisa Touch laser device for vaginal rejuvenation. The complaint, which was filed in the U.S. District Court, District of Massachusetts, on August 13th, seeks to represent medical practitioners who purchased … Continue reading

C.R. Bard Hernia Mesh Lawsuits Mount, With New Filing in Rhode Island

A woman from Rhode Island has filed a new hernia mesh lawsuit against C.R. Bard, Inc. over injuries she allegedly sustained from a defectively designed Ventralight ST Mesh patch. Ventralight ST Patch Failed, Removed Less than 2 Months After Implantation … Continue reading

Monsanto Roundup Lawsuits Surge in Wake of $289 Million Cancer Verdict

Bayer AG is now saddled with more than 8,000 Monsanto Roundup lawsuits, as filings surged in the wake of a $289 million cancer verdict awarded to a former California landscaper earlier this month. When Bayer completed its acquisition of Monsanto … Continue reading

Gilead Hit with New Lawsuits Over TDF HIV Antiviral Drugs in Louisiana

Two men in Louisiana have filed lawsuits over TDF HIV antiviral drugs, accusing Gilead of failing to fully disclose the potential for kidney damage and bone loss associated with Viread and Truvada. The lawsuits also accuse the pharmaceutical company of … Continue reading

Missouri Judge Affirms $4.7 Billion Talcum Powder Ovarian Cancer Verdict Against Johnson & Johnson

A Missouri judge has affirmed a $4.7 billion verdict awarded to 22 plaintiffs who alleged that asbestos in Johnson & Johnson’s popular talcum powder products caused ovarian cancer. The healthcare products giant, which has strongly denied that its talc-based powders … Continue reading

New Jersey Taxotere Lawsuits Granted Multicounty Litigation Status

The New Jersey Supreme Court has agreed to grant multicounty litigation status to all Taxotere permanent hair loss claims filed in the state’s Superior Courts. New Jersey Taxotere Litigation Heads to Middlesex County Superior Court According to a Notice to … Continue reading

Valsartan Class Action Lawsuit Filed in New York, as Recall Over Cancer Chemical Expands

A new class action lawsuit has been filed in New York federal court that seeks restitution for consumers who purchased valsartan tablets that may be tainted with a cancer-causing chemical. The tablets in question are among those included in a … Continue reading

Monsanto Hit with Massive $289 Million Cancer Verdict, as First Roundup Lawsuit Trial Concludes

Monsanto has been ordered to pay $289 million to a former groundskeeper who was diagnosed with non-Hodgkin’s lymphoma following exposure to the company’s popular Roundup weed killer. The trial was the first in a nationwide litigation that currently includes more … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content